Association of Pallidal Neurostimulation and Outcome Predictors With X-linked Dystonia Parkinsonism

Standard

Association of Pallidal Neurostimulation and Outcome Predictors With X-linked Dystonia Parkinsonism. / Brüggemann, Norbert; Domingo, Aloysius; Rasche, Dirk; Moll, Christian K E; Rosales, Raymond L; Jamora, Roland Dominic G; Hanssen, Henrike; Münchau, Alexander; Graf, Julia; Weissbach, Anne; Tadic, Vera; Diesta, Cid C; Volkmann, Jens; Kühn, Andrea; Münte, Thomas F; Tronnier, Volker; Klein, Christine.

In: JAMA NEUROL, Vol. 76, No. 2, 01.02.2019, p. 211-216.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

Brüggemann, N, Domingo, A, Rasche, D, Moll, CKE, Rosales, RL, Jamora, RDG, Hanssen, H, Münchau, A, Graf, J, Weissbach, A, Tadic, V, Diesta, CC, Volkmann, J, Kühn, A, Münte, TF, Tronnier, V & Klein, C 2019, 'Association of Pallidal Neurostimulation and Outcome Predictors With X-linked Dystonia Parkinsonism', JAMA NEUROL, vol. 76, no. 2, pp. 211-216. https://doi.org/10.1001/jamaneurol.2018.3777

APA

Brüggemann, N., Domingo, A., Rasche, D., Moll, C. K. E., Rosales, R. L., Jamora, R. D. G., Hanssen, H., Münchau, A., Graf, J., Weissbach, A., Tadic, V., Diesta, C. C., Volkmann, J., Kühn, A., Münte, T. F., Tronnier, V., & Klein, C. (2019). Association of Pallidal Neurostimulation and Outcome Predictors With X-linked Dystonia Parkinsonism. JAMA NEUROL, 76(2), 211-216. https://doi.org/10.1001/jamaneurol.2018.3777

Vancouver

Brüggemann N, Domingo A, Rasche D, Moll CKE, Rosales RL, Jamora RDG et al. Association of Pallidal Neurostimulation and Outcome Predictors With X-linked Dystonia Parkinsonism. JAMA NEUROL. 2019 Feb 1;76(2):211-216. https://doi.org/10.1001/jamaneurol.2018.3777

Bibtex

@article{66e9cc014234418db03e7a1886862092,
title = "Association of Pallidal Neurostimulation and Outcome Predictors With X-linked Dystonia Parkinsonism",
abstract = "Importance: Anecdotal evidence suggests that deep brain stimulation (DBS) of the internal globus pallidus (GPi) is effective in ameliorating dystonia in X-linked dystonia parkinsonism (XDP), a disease that is usually refractive to medical therapy.Objective: To determine the efficacy of GPi-DBS in a cohort of patients with XDP in a prospective study and identify predictors of postoperative outcomes.Design, Setting, and Participants: This observational prospective cohort study enrolled patients in February 2013 and was completed in December 2014. The patients were followed up for up to 46 months. Patients from the Philippines were treated in a single center in L{\"u}beck, Germany and followed up in the Philippines. Sixteen men with XDP (mean [SD] age, 40.9 [7.3] years; disease duration, 1-6 years) from the Philippines with predominant dystonia were selected.Exposures: All patients underwent bilateral GPi-DBS in L{\"u}beck, Germany.Main Outcomes and Measures: Clinical assessment included the motor parts of the Burke-Fahn-Marsden scale (BFMDRS-M) and the Unified Parkinson's Disease Rating Scale (UPDRS-III). T1-based basal ganglia volumetry was performed and correlated with postoperative outcomes.Results: The study participants included 16 Filipino men (mean age, 40.9 years). Masked video ratings revealed significant improvements of dystonia severity 1 week (-55%; range, -94% to 59%; P < .01) and 6 months (-59%; range, -100% to 22%; P < .001) after surgery. The UDPRS-III score also improved, albeit to a lesser extent (-19%; range, -54% to 95%; and -27%; range, -70% to 124%; respectively). Unmasked long-term follow-up confirmed the continued efficacy of GPi-DBS up to 46 months after surgery. Important secondary end points improved, including activities of daily living, pain severity, weight, and quality of life. Caudate atrophy was a predictor of a less beneficial outcome (r = 0.817, P = .004).Conclusions and Relevance: Internal globus pallidus DBS had a positive association in XDP with predominant dystonia (the primary end point) and contributed to an improved quality of life (the secondary end point). The response to DBS occurred within 1 week. Given the inverse correlation of postoperative benefit and caudate atrophy, GPi-DBS should be considered early during the disease course. Close international collaboration, training, and funding from multiple sources enabled the sustainable follow-up of patients with XDP in the Philippines.",
keywords = "Journal Article",
author = "Norbert Br{\"u}ggemann and Aloysius Domingo and Dirk Rasche and Moll, {Christian K E} and Rosales, {Raymond L} and Jamora, {Roland Dominic G} and Henrike Hanssen and Alexander M{\"u}nchau and Julia Graf and Anne Weissbach and Vera Tadic and Diesta, {Cid C} and Jens Volkmann and Andrea K{\"u}hn and M{\"u}nte, {Thomas F} and Volker Tronnier and Christine Klein",
year = "2019",
month = feb,
day = "1",
doi = "10.1001/jamaneurol.2018.3777",
language = "English",
volume = "76",
pages = "211--216",
journal = "JAMA NEUROL",
issn = "2168-6149",
publisher = "American Medical Association",
number = "2",

}

RIS

TY - JOUR

T1 - Association of Pallidal Neurostimulation and Outcome Predictors With X-linked Dystonia Parkinsonism

AU - Brüggemann, Norbert

AU - Domingo, Aloysius

AU - Rasche, Dirk

AU - Moll, Christian K E

AU - Rosales, Raymond L

AU - Jamora, Roland Dominic G

AU - Hanssen, Henrike

AU - Münchau, Alexander

AU - Graf, Julia

AU - Weissbach, Anne

AU - Tadic, Vera

AU - Diesta, Cid C

AU - Volkmann, Jens

AU - Kühn, Andrea

AU - Münte, Thomas F

AU - Tronnier, Volker

AU - Klein, Christine

PY - 2019/2/1

Y1 - 2019/2/1

N2 - Importance: Anecdotal evidence suggests that deep brain stimulation (DBS) of the internal globus pallidus (GPi) is effective in ameliorating dystonia in X-linked dystonia parkinsonism (XDP), a disease that is usually refractive to medical therapy.Objective: To determine the efficacy of GPi-DBS in a cohort of patients with XDP in a prospective study and identify predictors of postoperative outcomes.Design, Setting, and Participants: This observational prospective cohort study enrolled patients in February 2013 and was completed in December 2014. The patients were followed up for up to 46 months. Patients from the Philippines were treated in a single center in Lübeck, Germany and followed up in the Philippines. Sixteen men with XDP (mean [SD] age, 40.9 [7.3] years; disease duration, 1-6 years) from the Philippines with predominant dystonia were selected.Exposures: All patients underwent bilateral GPi-DBS in Lübeck, Germany.Main Outcomes and Measures: Clinical assessment included the motor parts of the Burke-Fahn-Marsden scale (BFMDRS-M) and the Unified Parkinson's Disease Rating Scale (UPDRS-III). T1-based basal ganglia volumetry was performed and correlated with postoperative outcomes.Results: The study participants included 16 Filipino men (mean age, 40.9 years). Masked video ratings revealed significant improvements of dystonia severity 1 week (-55%; range, -94% to 59%; P < .01) and 6 months (-59%; range, -100% to 22%; P < .001) after surgery. The UDPRS-III score also improved, albeit to a lesser extent (-19%; range, -54% to 95%; and -27%; range, -70% to 124%; respectively). Unmasked long-term follow-up confirmed the continued efficacy of GPi-DBS up to 46 months after surgery. Important secondary end points improved, including activities of daily living, pain severity, weight, and quality of life. Caudate atrophy was a predictor of a less beneficial outcome (r = 0.817, P = .004).Conclusions and Relevance: Internal globus pallidus DBS had a positive association in XDP with predominant dystonia (the primary end point) and contributed to an improved quality of life (the secondary end point). The response to DBS occurred within 1 week. Given the inverse correlation of postoperative benefit and caudate atrophy, GPi-DBS should be considered early during the disease course. Close international collaboration, training, and funding from multiple sources enabled the sustainable follow-up of patients with XDP in the Philippines.

AB - Importance: Anecdotal evidence suggests that deep brain stimulation (DBS) of the internal globus pallidus (GPi) is effective in ameliorating dystonia in X-linked dystonia parkinsonism (XDP), a disease that is usually refractive to medical therapy.Objective: To determine the efficacy of GPi-DBS in a cohort of patients with XDP in a prospective study and identify predictors of postoperative outcomes.Design, Setting, and Participants: This observational prospective cohort study enrolled patients in February 2013 and was completed in December 2014. The patients were followed up for up to 46 months. Patients from the Philippines were treated in a single center in Lübeck, Germany and followed up in the Philippines. Sixteen men with XDP (mean [SD] age, 40.9 [7.3] years; disease duration, 1-6 years) from the Philippines with predominant dystonia were selected.Exposures: All patients underwent bilateral GPi-DBS in Lübeck, Germany.Main Outcomes and Measures: Clinical assessment included the motor parts of the Burke-Fahn-Marsden scale (BFMDRS-M) and the Unified Parkinson's Disease Rating Scale (UPDRS-III). T1-based basal ganglia volumetry was performed and correlated with postoperative outcomes.Results: The study participants included 16 Filipino men (mean age, 40.9 years). Masked video ratings revealed significant improvements of dystonia severity 1 week (-55%; range, -94% to 59%; P < .01) and 6 months (-59%; range, -100% to 22%; P < .001) after surgery. The UDPRS-III score also improved, albeit to a lesser extent (-19%; range, -54% to 95%; and -27%; range, -70% to 124%; respectively). Unmasked long-term follow-up confirmed the continued efficacy of GPi-DBS up to 46 months after surgery. Important secondary end points improved, including activities of daily living, pain severity, weight, and quality of life. Caudate atrophy was a predictor of a less beneficial outcome (r = 0.817, P = .004).Conclusions and Relevance: Internal globus pallidus DBS had a positive association in XDP with predominant dystonia (the primary end point) and contributed to an improved quality of life (the secondary end point). The response to DBS occurred within 1 week. Given the inverse correlation of postoperative benefit and caudate atrophy, GPi-DBS should be considered early during the disease course. Close international collaboration, training, and funding from multiple sources enabled the sustainable follow-up of patients with XDP in the Philippines.

KW - Journal Article

U2 - 10.1001/jamaneurol.2018.3777

DO - 10.1001/jamaneurol.2018.3777

M3 - SCORING: Journal article

C2 - 30508028

VL - 76

SP - 211

EP - 216

JO - JAMA NEUROL

JF - JAMA NEUROL

SN - 2168-6149

IS - 2

ER -